India CROs Wary As Ministry Ordered By Supreme Court To Explain Cases
This article was originally published in PharmAsia News
Executive Summary
As India's health ministry prepares its justification to the Supreme Court for resuming approvals of clinical trials, the clinical research industry is watching, fearful more of its business will be lost to Malaysia, Singapore and other more favorable countries.